Agilent acquires Virtual Control's lab AI technology

By LabPulse.com staff writers

February 17, 2022 -- Agilent has acquired artificial intelligence (AI) technology developed by Virtual Control, a software development company for laboratory solutions. Agilent will integrate the new technology, called ACIES, into its MassHunter software package.

Specifically, ACIES will be used with liquid chromatography/mass spectrometry (LC/MS) and gas chromatography and MS (GS/MS) instruments. It automates the labor-intensive task of GS/MS data analysis, improving efficiency in the laboratory workflow from sampling to reporting, Agilent said.

As part of the acquisition, Agilent obtained the software and other assets associated with ACIES, and as part of the deal, core members of the ACIES team will now be Agilent employees, Agilent said.

Agilent highlights automation platforms at SLAS 2022
Agilent Technologies highlighted the company's integrated automation platforms, including a live cell analysis system at the Society for Laboratory Automation...
Agilent receives FDA approval for breast cancer assay
Agilent Technologies has received approval from the U.S. Food and Drug Administration (FDA) for its Ki-67 IHC MIB-1 pharmDx assay. The assay can help...
Agilent enters digital pathology with Visiopharm deal
Agilent Technologies and Visiopharm have signed a worldwide distribution agreement that allows Agilent to co-market Visiopharm's portfolio of digital...
Agilent secures expanded CE Mark for cancer assay
Agilent Technologies has received an expanded CE Mark that will allow its PD-L1 IHC 22C3 pharmDx assay -- a companion diagnostic for the Keytruda chemotherapy...

Copyright © 2022 LabPulse.com

Last Updated ls 2/17/2022 10:41:58 AM